Want to join the conversation?
For 3Q16, $FFIV said it has set a revenue goal of $490-500MM. $FFIV expects 3Q16 GAAP EPS of $1.29-1.32 and non-GAAP EPS of $1.77-1.80. Excluding stock-based compensation expense and amortization of purchased intangible assets, net income is expected to be $119.1-121.2MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?